Indicatie
Luveris in association with a follicle-stimulating-hormone (FSH) preparation is recommended for the stimulation of follicular development in women with severe luteinising-hormone (LH) and FSH deficiency. In clinical trials, these patients were defined by an endogenous serum LH level <1.2 IU/l.
In andere landen
Dezelfde werkzame stoffen in andere registers, met hetzelfde merk eerst.
Nationale vermeldingen
De nationale registers waarin dit EU-geneesmiddel staat.
- LuverisCanada · 75 UNIT / VIAL · Powder For Solution · Emd Serono, A Division of Emd INC., CanadaZelfde merk
- LuverisCanada · 450 UNIT / 0.72 ML · Solution · Emd Serono, A Division of Emd INC., CanadaZelfde merk
- Luveris 75 Ui, Polvo y Disolvente Para Solucion InyectableSpanje · 75 UI · polvo y disolvente para solución inyectable · Merck Europe B.V.Zelfde merk